Engineering advanced logic and distributed computing in human CAR immune cells
Open Access
- 4 February 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Nature Communications
- Vol. 12 (1), 1-14
- https://doi.org/10.1038/s41467-021-21078-7
Abstract
The immune system is a sophisticated network of different cell types performing complex biocomputation at single-cell and consortium levels. The ability to reprogram such an interconnected multicellular system holds enormous promise in treating various diseases, as exemplified by the use of chimeric antigen receptor (CAR) T cells as cancer therapy. However, most CAR designs lack computation features and cannot reprogram multiple immune cell types in a coordinated manner. Here, leveraging our split, universal, and programmable (SUPRA) CAR system, we develop an inhibitory feature, achieving a three-input logic, and demonstrate that this programmable system is functional in diverse adaptive and innate immune cells. We also create an inducible multi-cellular NIMPLY circuit, kill switch, and a synthetic intercellular communication channel. Our work highlights that a simple split CAR design can generate diverse and complex phenotypes and provide a foundation for engineering an immune cell consortium with user-defined functionalities.Keywords
Funding Information
- National Science Foundation (162457)
- U.S. Department of Health & Human Services | NIH | National Institute of Biomedical Imaging and Bioengineering (1R56EB027729-01A1, R01EB029483)
- U.S. Department of Health & Human Services | NIH | National Institute of Biomedical Imaging and Bioengineering
- U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (1R01GM129011-01)
This publication has 48 references indexed in Scilit:
- Disruption of a self-amplifying catecholamine loop reduces cytokine release syndromeNature, 2018
- Fundamental Mechanisms of Immune Checkpoint Blockade TherapyCancer Discovery, 2018
- Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell LymphomaThe New England Journal of Medicine, 2017
- Integrating Proteomics and Transcriptomics for Systematic Combinatorial Chimeric Antigen Receptor Therapy of AMLCancer Cell, 2017
- γδ T-cell reconstitution after HLA-haploidentical hematopoietic transplantation depleted of TCR-αβ+/CD19+ lymphocytesBlood, 2015
- Treg and CTLA-4: Two intertwining pathways to immune toleranceJournal of Autoimmunity, 2013
- Chimeric Antigen Receptor T Cells with Dissociated Signaling Domains Exhibit Focused Antitumor Activity with Reduced Potential for Toxicity In VivoCancer Immunology Research, 2013
- GMP-Compliant, Large-Scale Expanded Allogeneic Natural Killer Cells Have Potent Cytolytic Activity against Cancer Cells In Vitro and In VivoPLOS ONE, 2013
- Combinatorial antigen recognition with balanced signaling promotes selective tumor eradication by engineered T cellsNature Biotechnology, 2012
- Selection of tumor antigens as targets for immune attack using immunohistochemistry: I. Focus on gangliosidesInternational Journal of Cancer, 1997